Iovanace Biotherapeutics (IOVA) PT Raised to $18 at Wells Fargo

September 30, 2026 6:09 AM

Wells Fargo analyst Nick Abbott raised the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $18.00 (from $14.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found